Stockscreener 앱 받기
7.02
0.00%
0.00
시간 외 거래:
7.02
전일 마감가:
$7.02
열려 있는:
$7.06
하루 거래량:
101.38K
Relative Volume:
0.89
시가총액:
$64.95M
수익:
-
순이익/손실:
$-6.42M
주가수익비율:
-1.2533
EPS:
-5.6013
순현금흐름:
$-7.45M
1주 성능:
+4.15%
1개월 성능:
-19.31%
6개월 성능:
-31.51%
1년 성능:
-43.70%
1일 변동 폭
$7.0049
$7.5999
1주일 범위
$6.70
$7.5999
52주 변동 폭
$1.80
$16.94
Cervomed Inc Stock (CRVO) Company Profile
명칭
Cervomed Inc
전화
(617) 744-4400
주소
20 PARK PLAZA, BOSTON
CRVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
7.02 | 64.95M | 0 | -6.42M | -7.45M | -5.6013 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2024-12-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-12-11 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2024-12-11 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2024-12-10 | 다운그레이드 | D. Boral Capital | Buy → Hold |
| 2024-12-06 | 개시 | ROTH MKM | Buy |
| 2024-12-05 | 개시 | H.C. Wainwright | Buy |
| 2024-09-18 | 개시 | Chardan Capital Markets | Buy |
| 2024-07-26 | 개시 | Morgan Stanley | Overweight |
| 2024-02-15 | 개시 | Canaccord Genuity | Buy |
| 2020-11-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | 개시 | H.C. Wainwright | Buy |
모두보기
Cervomed Inc 주식(CRVO)의 최신 뉴스
CervoMed (CRVO) Analyst Maintains Buy Rating with Price Target o - GuruFocus
CervoMed (CRVO) Gains FDA Support for Phase 3 Trial on Dementia Treatment - GuruFocus
CervoMed stock rises after FDA alignment on Phase 3 trial design - Investing.com UK
CervoMed announces FDA alignment on neflamapimod registration path - TipRanks
CervoMed announces alignment with FDA on registration path for neflamapimod in dementia with Lewy bodies - MarketScreener
CervoMed Announces Alignment With FDA On Registration Path For Neflamapimod In Dementia With Lewy Bodies - TradingView
CervoMed Gains FDA Alignment for Phase 3 Trial - TipRanks
CervoMed Inc Aligns with FDA on Phase 3 Trial for Dementia Drug - TradingView
FDA aligns with CervoMed on phase 3 trial design for DLB treatment - Investing.com
CervoMed Announces Alignment with FDA on Registration Path for Neflamapimod in Dementia with Lewy Bodies - Stock Titan
Forecasting CervoMed Inc. price range with options dataQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Should you hold or exit CervoMed Inc. nowWall Street Watch & Capital Efficient Trade Techniques - newser.com
Will CervoMed Inc. stock outperform Nasdaq indexJuly 2025 Recap & Capital Efficient Trade Techniques - newser.com
How to integrate CervoMed Inc. into portfolio analysis toolsJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - newser.com
Tools to monitor CervoMed Inc. recovery probabilityJuly 2025 PreEarnings & Stepwise Trade Execution Plans - newser.com
Will CervoMed Inc. (DP8) stock keep high P E multiplesQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Can technical indicators confirm CervoMed Inc.’s reversalGold Moves & Verified Momentum Stock Alerts - newser.com
Why CervoMed Inc. (DP8) stock stays undervaluedSell Signal & Technical Pattern Recognition Alerts - newser.com
Detecting support and resistance levels for CervoMed Inc.Profit Target & Community Consensus Trade Alerts - newser.com
What RSI levels show for CervoMed Inc. (DP8) stockMarket Risk Report & Capital Efficiency Focused Ideas - newser.com
Is CervoMed Inc. stock a defensive play in 20252025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
How CervoMed Inc. (DP8) stock gains from tech spendingJuly 2025 Pullbacks & Detailed Earnings Play Strategies - newser.com
Applying Elliott Wave Theory to CervoMed Inc.July 2025 Drop Watch & Expert Curated Trade Setup Alerts - newser.com
CervoMed Inc. stock trend outlook and recovery pathJobs Report & Smart Swing Trading Alerts - newser.com
Is CervoMed Inc. stock supported by strong cash flowsMarket Weekly Review & Daily Entry Point Alerts - newser.com
Will CervoMed Inc. stock reach all time highs in 2025Wall Street Watch & Expert Verified Stock Movement Alerts - newser.com
Using flow based indicators on CervoMed Inc.Earnings Trend Report & Trade Opportunity Analysis Reports - newser.com
How CervoMed Inc. (DP8) stock reacts to fiscal policiesWeekly Investment Summary & Safe Capital Growth Tips - newser.com
Will CervoMed Inc. (DP8) stock benefit from sector leadershipVolume Spike & Technical Confirmation Trade Alerts - newser.com
Can CervoMed Inc. rally from current levelsJuly 2025 Macro Moves & Free Technical Pattern Based Buy Signals - newser.com
Full technical analysis of CervoMed Inc. stock2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Is CervoMed Inc. a candidate for recovery playEntry Point & Technical Pattern Alert System - newser.com
Cervomed Inc (CRVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):